drugset / Trial / NCT07070674
A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.
Non-randomizedSequentialOpen-labelTreatment
Summary
The study was an open-label, single-arm, dose-escalation, Phase Ib, multi-center study to investigate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of AC-003 in patients with grade II-IV SR-aGVHD.
Timeline
- Start
- 2024-07-25
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AC-003 | Unknown | — | Oral |